1
项与 Neural precursor cell therapy (S Biomedics) 相关的临床试验A Single Center, Open Label, Single Group, Phase 1/2a Clinical Study to Evaluate the Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC Derived From hESC Line in AIS-A Level of Sub-acute SCI(From 7 to 60 Days)
This study intends to evaluate the safety and exploratory efficacy of transplantation therapy using neural precursor cells (PSA-NCAM(+) NPC) derived from the human embryonic stem cell line for the treatment of paralysis and other related symptoms from sub-acute spinal cord injury.
100 项与 Neural precursor cell therapy (S Biomedics) 相关的临床结果
100 项与 Neural precursor cell therapy (S Biomedics) 相关的转化医学
100 项与 Neural precursor cell therapy (S Biomedics) 相关的专利(医药)
100 项与 Neural precursor cell therapy (S Biomedics) 相关的药物交易